Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus

Authors:
  • MYMasahiro Yamamoto
    Masahiro Yamamoto
  • MYMika Yamauchi
    Mika Yamauchi
  • SYShozo Yano
    Shozo Yano
  • TSToshitsugu Sugimoto
    Toshitsugu Sugimoto

Abstract
Background: Although, adiponectin might be associated with bone metabolism, the relationships between serum adiponectin and bone mineral density (BMD) as well as vertebral fracture in type 2 diabetes are still unclear.Objective and methods: We investigated the relationships between each of serum total and high molecular weight (HMW) adiponectin versus BMD, bone markers, and the presence of vertebral fractures in a total of 231 men and 170 post-menopausal women with type 2 diabetes.Results: Multiple regression analysis adjusted for age, duration of diabetes, BMI, serum creatinine, and HbA1c showed that serum total adiponectin was negatively correlated with BMD at the total, lumbar spine, and femoral neck (r=−0.165, Pr=−0.187, Pr=−0.136, Pr=0.148, Pr=−0.146, PPPP<0.05 respectively), but not in post-menopausal women.Conclusions: Serum adiponectin could be associated with BMD and turnover and clinically useful for assessing the risk of vertebral fractures in type 2 diabetic men.